Endonovo Therapeutics Highlights Feasibility Study Results of Its Electroceutical Therapy in Reducing Proteinuria in Chronic Kidney Disease Patients
May 01, 2018 07:35 ET
|
Endonovo Therapeutics, Inc.
Company to Conduct Larger Clinical Study to Evaluate Its Electroceutical™ Therapy in Chronic Kidney Disease LOS ANGELES, CA, May 01, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics,...
DiaMedica Therapeutics Announces Appointment of Scott Kellen as Chief Financial Officer
April 05, 2018 07:15 ET
|
DiaMedica Therapeutics Inc.
MINNEAPOLIS, April 05, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “Company”) (TSX-V:DMA) (OTCQB:DMCAF) is pleased to announce the appointment of Mr. Scott Kellen as Chief Financial...
DiaMedica Therapeutics Announces Final Closing of Private Placement
March 29, 2018 18:08 ET
|
DiaMedica Therapeutics Inc.
MINNEAPOLIS, March 29, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “Company” and “DiaMedica”) (TSX-V:DMA) (OTCQB:DMCAF) is pleased to announce the successful completion of the second...
DiaMedica Therapeutics Announces Closing of Private Placement
March 20, 2018 17:40 ET
|
DiaMedica Therapeutics Inc.
MINNEAPOLIS, March 20, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “Company”) (TSX-V:DMA) (OTCQB:DMCAF) is pleased to announce the successful completion of the first closing of a...
DiaMedica Announces First Enrollment in its PHASE 2 “REMEDY” TRIAL for Acute Ischemic Stroke
February 22, 2018 07:00 ET
|
DiaMedica Therapeutics Inc.
DM199 may offer an effective and safe treatment with a significantly longer treatment window (24 hours) compared to the current standard of careREMEDY trial lead by prominent neurologist Dr. Bruce...
DiaMedica to Present at the 14th Annual Noble Investor Conference
January 29, 2018 08:45 ET
|
DiaMedica Therapeutics Inc.
MINNEAPOLIS, Jan. 29, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (TSXV:DMA) (OTCQB:DMCAF), today announced that Mr. Rick Pauls, its President and CEO, will present at Noble Capital...
Streetwise Reports Examines Analyst’s View of ‘One of the Most Undervalued Biotech Companies in Canada’
December 07, 2017 08:45 ET
|
Streetwise Reports Llc
SAN FRANCISCO, Dec. 07, 2017 (GLOBE NEWSWIRE) -- David Kideckel, an analyst with Beacon Securities Ltd., explained the investment thesis for this clinical-stage life sciences firm. Included in this...
Satellite Healthcare to Present at American Society of Nephrology Annual Kidney Week Conference
October 31, 2017 09:03 ET
|
Satellite Healthcare
SAN JOSE, Calif., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Satellite Healthcare, a leading not-for-profit dialysis provider, today announced it will present three posters and host a NephTalk lounge for...
Satellite Healthcare Awards $800,000 in Applied Pragmatic Clinical Research Grants
October 04, 2017 15:42 ET
|
Satellite Healthcare
SAN JOSE, Calif., Oct. 04, 2017 (GLOBE NEWSWIRE) -- Satellite Healthcare, a leading not-for-profit dialysis provider, today awarded $800,000 in Applied Pragmatic Clinical Research Grants to four...
Satellite Healthcare Recognizes National Kidney Month with Educational Presentations at the Annual Dialysis Conference
March 09, 2017 09:00 ET
|
Satellite Healthcare
SAN JOSE, Calif., March 09, 2017 (GLOBE NEWSWIRE) -- Satellite Healthcare, a leading national not-for-profit dialysis care provider, today recognizes World Kidney Day and National Kidney Month by...